The FDA has updated the labels for Pfizer and Moderna COVID-19 vaccines

The FDA has updated the labels for Pfizer and Moderna COVID-19 vaccines to highlight the risk of myocarditis and pericarditis, particularly in young males, which may affect public perception and regulatory scrutiny.

The FDA updated the labels for Pfizer and Moderna COVID-19 vaccines to emphasize the risk of myocarditis and pericarditis, particularly in young males, with an estimated 8 cases of heart inflammation per 1 million doses.

Key information on approval prospects and potential delays/issues

The FDA updated the labels for Moderna’s COVID-19 vaccine to include warnings about myocarditis and pericarditis risks, which could influence public perception and regulatory scrutiny.